Kenji Ono

Title: Kenji Ono - Innovator in Streptokinase Protein Development

Introduction

Kenji Ono is a notable inventor based in Tokushima, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of mutated streptokinase proteins. His innovative work has implications for medical treatments and therapeutic applications.

Latest Patents

Kenji Ono holds 1 patent related to his invention of mutated streptokinase proteins. This patent describes a novel chemically synthesized gene that includes a base sequence coding for the primary amino acid sequence of natural-type streptokinase. The invention also encompasses a corresponding plasmid recombinant, a transformant, and a process for preparing streptokinase through the incubation of the transformant. Additionally, it details novel streptokinase derivative proteins that possess streptokinase activity and a modified primary amino acid sequence, which is deficient in amino acid residues at the 373-position to the C-terminus.

Career Highlights

Kenji Ono is currently employed at Otsuka Pharmaceutical Factory, Inc. His work at this esteemed company has allowed him to focus on innovative research and development in the pharmaceutical sector. His contributions have been instrumental in advancing the understanding and application of streptokinase proteins.

Collaborations

Throughout his career, Kenji has collaborated with notable colleagues, including Eiji Majima and Tamiki Katano. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective fields.

Conclusion

Kenji Ono's work in the development of mutated streptokinase proteins exemplifies the impact of innovation in biotechnology. His contributions continue to influence medical research and therapeutic applications, showcasing the importance of inventors in advancing science and technology.